Catalyst Wire Dossier Catalyst Wire Dossier

Interleukin-5 antagonists

null · null
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Interleukin-5 antagonists, covering 2024-04-22 to 2024-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists [Phase 1]

See pricing